Top Markets
#1 Islamic Coin Islamic Coin +151.48%
#2 DOVU DOVU +48.35%
#3 Velvet Velvet +35.55%
#4 Black Phoenix Black Phoenix +34.64%
#5 Akedo Akedo +31.02%
#6 Cross Cross +19.08%
#7 Cap Cap +15.07%
#8 DoubleZero DoubleZero +14.72%
#9 Fake World Assets Fake World Assets +10.11%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +10.07%
Coin of the day
Islamic Coin Islamic Coin
設定
言語
日本
通貨
USD
テーマ
BBS-Bioactive Bone Substitutes Oyj BBS-Bioactive Bone Substitutes Oyj

BBS-Bioactive Bone Substitutes Oyj

BONEH
株式のランク #39433
BBS-Bioactive Bone Substitutes Oyj operates as a Finnish biomedical technology... BBS-Bioactive Bone Substitutes Oyj operates as a Finnish biomedical technology firm, dedicated to innovating, manufacturing, and commercializing bioactive medical devices and implants for orthopedic surgical applications. The company's key offering, ARTEBONE, is an orthobiological product composed of tricalcium phosphate and a comprehensive spectrum of natural bone proteins. This solution is predominantly used for addressing bone deficiencies and aiding healing processes, especially in extremities such as the foot and ankle. BBS-Bioactive Bone Substitutes Plc commenced operations in 1991 and has its corporate headquarters situated in Oulu, Finland.
株価
$0.05828914
最終同期: 2025-03-10
時価総額
$495.40K
変化（1日）
-0.02%
変化（1年）
0.00%
国
FI
取引 BBS-Bioactive Bone Substitutes Oyj (BONEH)

カテゴリー

Healthcare
BBS-Bioactive Bone Substitutes Oyj（BONEH）の利益
2026 時点の利益 TTM: 0
BBS-Bioactive Bone Substitutes Oyj の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
BBS-Bioactive Bone Substitutes Oyj の利益の推移（2026 〜 2026）
各年末の利益
年 利益 変化
提供された日付のデータは十分ではありません。
同業他社の利益
企業 利益 利益の差 国
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
$7.51B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
$5.15B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
$5.56B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
$3.86B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
$1.42B -
US